Myopic Monovision: EDOF vs. Monofocal IOL

Sponsor
Vienna Institute for Research in Ocular Surgery (Other)
Overall Status
Recruiting
CT.gov ID
NCT05194670
Collaborator
(none)
62
1
2
84
0.7

Study Details

Study Description

Brief Summary

Comparison of EDOF IOLs versus monofocal IOLs with mini-monovision concerning intermediate and near visual acuity.

Condition or Disease Intervention/Treatment Phase
  • Device: enhanced depth of focus IOL
  • Device: monofocal IOL
N/A

Detailed Description

Spectacle independence is one of the main aims in modern cataract surgery. Although bilateral monofocal IOL implantation, aiming for emmetropia or low myopia, leads to high levels of patient satifsfaction in distance vision, spectacle dependence for reading and other near vision tasks is the usual result.

There are different techniques to reduce spectacle dependence, the most common one is the use of multifocal IOLs. However, a variable number of patients complain of problems, such as glare or haloes. It appears that multifocal IOL technology does lead to less satisfying results in patients with pre-operative myopia. These patients are used to very good near vision when taking off their spectacles. Many of these patients would prefer to keep their distance spectacles and ideally would like to function well at intermediate and near distance without glasses for e.g. reading and computer- or household work.

One option to enhance intermediate vision and to leave patients with good contrast sensitivity is the use of extended depth of focus (EDOF) IOLs. One example is the ACUNEX Vario AN6V with a near add of 1.50 D. In particular, this design provides improved vision at a distance of 66 cm and more. Additional key features of the low-add IOL include good contrast sensitivity for twilight vision, optimized depth of focus, and natural imaging quality and color sensitivity.

Another option to allow spectacle independence is (mini-)monovision. For some people, who are in need of intermediate and near reading vision most of the time, mini-monovision with one eye having intermediate (arms length) and one eye having near (reading) vision is a good option ("myopic monovision").

Hence, the aim of the study is to analyse intermediate and near vision outcomes in myopic patients with either EDOF IOLs or monofocal IOLs with mini-monovision.

124 eyes of 62 patients will be included into this study. According to randomization, 31 patients will receive the EDOF IOLs (Acunex Vario AN6V) bilaterally, whereas in the other 31 patients a monofocal IOL (Acunex AN6) with mini-monovision will be implanted bilaterally. Follow-Up visits will be 1 hour, 1 week, and 2 months after surgery. A slit lamp examination, autorefraction and subjective refraction as well as visual acuity testing, reading performance, stereo vision testing and defocus curve assessment will be performed at this visits.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison Between Bilateral Extended Depth of Focus (EDOF) Intraocular Lens Myopic Monovision and Monofocal Intraocular Lens Myopic Monovision for Myopic Patients: a Randomised Trial
Actual Study Start Date :
Aug 1, 2017
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Acunex Vario AN6V

Patient will receive the enhanced depth of focus IOL during cataract surgery

Device: enhanced depth of focus IOL
Acunex Vario AN6V, enhanced depth of focus IOL

Experimental: Acunex AN6

Patient will receive the monofocal IOL during cataract surgery

Device: monofocal IOL
Acunex AN6, monofocal IOL

Outcome Measures

Primary Outcome Measures

  1. Spectacle independence [24 months]

    Spectacle independence will be assessed using a questionnaire and compared between patients with EDOF IOLs and patients with the monofocal IOL

Secondary Outcome Measures

  1. Visual acuity [24 months]

    Visual acuity will be assessed using ETDRS charts and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs

  2. Reading speed [24 months]

    Reading speed will be analysed by using the Salzburg Reading Desk and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs

  3. Stereo vision [24 months]

    Stereo vision will be analysed by using a 3D-computer program and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 105 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age-related cataract in both eyes

  • bilateral cataract surgery

  • motivated to be less spectacle dependent in the intermediate to near vision range

  • expected CDVA of 0.8 snellen or better

  • myopic patients with shorter eye having an axial length of at least 25.5 mm

  • age 21 and older

  • planned postoperative astigmatis lower than or 0.75 D

  • written informed consent prior to recruitment

Exclusion Criteria:
  • pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)

  • retinitis pigmentosa

  • chronic uveitis

  • amblyopia

  • pupil decentration > 0.8 mm, pupil size < 2.8 mm

  • preceded retinal surgery

  • preceded LASIK

  • any ophthalmic abnormality that could compromise visual function or the measurements

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna Vienna Austria 1140

Sponsors and Collaborators

  • Vienna Institute for Research in Ocular Surgery

Investigators

  • Principal Investigator: Oliver Findl, MD, Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prim. Prof. Dr. Oliver Findl, MBA, Principal Investigator, Vienna Institute for Research in Ocular Surgery
ClinicalTrials.gov Identifier:
NCT05194670
Other Study ID Numbers:
  • Myopic Monovision
First Posted:
Jan 18, 2022
Last Update Posted:
Jan 18, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prim. Prof. Dr. Oliver Findl, MBA, Principal Investigator, Vienna Institute for Research in Ocular Surgery
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 18, 2022